Home Cart 0 Sign in  
X

[ CAS No. 3541-37-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3541-37-5
Chemical Structure| 3541-37-5
Chemical Structure| 3541-37-5
Structure of 3541-37-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3541-37-5 ]

Related Doc. of [ 3541-37-5 ]

Alternatived Products of [ 3541-37-5 ]

Product Details of [ 3541-37-5 ]

CAS No. :3541-37-5 MDL No. :MFCD01075041
Formula : C9H6OS Boiling Point : -
Linear Structure Formula :- InChI Key :NXSVNPSWARVMAY-UHFFFAOYSA-N
M.W : 162.21 Pubchem ID :736500
Synonyms :

Calculated chemistry of [ 3541-37-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.21
TPSA : 45.31 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.83
Log Po/w (XLOGP3) : 2.74
Log Po/w (WLOGP) : 2.71
Log Po/w (MLOGP) : 1.81
Log Po/w (SILICOS-IT) : 3.81
Consensus Log Po/w : 2.58

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.11
Solubility : 0.126 mg/ml ; 0.000774 mol/l
Class : Soluble
Log S (Ali) : -3.35
Solubility : 0.0731 mg/ml ; 0.000451 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.28
Solubility : 0.0851 mg/ml ; 0.000525 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.69

Safety of [ 3541-37-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3541-37-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3541-37-5 ]
  • Downstream synthetic route of [ 3541-37-5 ]

[ 3541-37-5 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 50-00-0 ]
  • [ 95-15-8 ]
  • [ 5381-20-4 ]
  • [ 3541-37-5 ]
Reference: [1] Synlett, 2004, # 9, p. 1575 - 1576
  • 2
  • [ 3541-37-5 ]
  • [ 17890-56-1 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 9, p. 2278 - 2281
[2] Journal of Organic Chemistry, 2007, vol. 72, # 5, p. 1634 - 1638
[3] Acta Chemica Scandinavica, 1996, vol. 50, # 1, p. 71 - 76
[4] Journal of Medicinal Chemistry, 2002, vol. 45, # 20, p. 4559 - 4570
[5] Patent: US2005/176769, 2005, A1, . Location in patent: Page/Page column 48
[6] Chemistry - A European Journal, 2006, vol. 12, # 10, p. 2739 - 2744
[7] Tetrahedron Asymmetry, 2008, vol. 19, # 4, p. 500 - 511
  • 3
  • [ 67-56-1 ]
  • [ 68-12-2 ]
  • [ 95-15-8 ]
  • [ 3541-37-5 ]
  • [ 22913-24-2 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 0.5 h;
Stage #2: at -78 - 20℃; for 2 h;
General procedure: n-BuLi (1.67 M solution in hexane, 1.3 mL, 2.2 mmol) was added dropwise into a solution of p-bromoanisole (383 mg, 2.0 mmol) in THF (3 mL) at -78 °C for 30 min. Then, DMF (0.22 mL, 2.2 mmol) was added to the mixture and the obtained mixture was stirred at rt. After 2 h at the same temperature, THF was removed. Then, MeOH (3 mL) was added to the residue and the mixture was stirred at room temperature. After 30 min, I2 (1523 mg, 6 mmol) and K2CO3 (829 mg, 6 mmol) were added at 0 °C and the obtained mixture was stirred for 22 h at rt. The reaction mixture was quenched with satd aq Na2SO3 (5 mL) and was extracted with CHCl3 (3.x.20 mL). The organic layer was washed with brine and dried over Na2SO4 to provide methyl 4-methoxy-1-benzoate in 82percent yield. If necessary, the product was purified by short column chromatography (SiO2:hexane:EtOAc=9:1) to give pure methyl 4-methoxybenzoate as a colorless oil.
Reference: [1] Tetrahedron, 2012, vol. 68, # 24, p. 4701 - 4709
  • 4
  • [ 67-56-1 ]
  • [ 3541-37-5 ]
  • [ 22913-24-2 ]
Reference: [1] Chemical Science, 2016, vol. 7, # 7, p. 4428 - 4434
  • 5
  • [ 3541-37-5 ]
  • [ 22913-24-2 ]
Reference: [1] Green Chemistry, 2018, vol. 20, # 17, p. 3931 - 3943
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3541-37-5 ]

Aldehydes

Chemical Structure| 5834-16-2

[ 5834-16-2 ]

3-Methyl-2-thiophenecarboxaldehyde

Similarity: 0.83

Chemical Structure| 5381-20-4

[ 5381-20-4 ]

Benzo[b]thiophene-3-carbaldehyde

Similarity: 0.79

Chemical Structure| 932-41-2

[ 932-41-2 ]

2,3-Thiophenedicarboxaldehyde

Similarity: 0.78

Chemical Structure| 99902-07-5

[ 99902-07-5 ]

2-(Thiophen-2-yl)benzaldehyde

Similarity: 0.75

Chemical Structure| 107834-03-7

[ 107834-03-7 ]

4-(Thiophen-2-yl)benzaldehyde

Similarity: 0.75

Related Parent Nucleus of
[ 3541-37-5 ]

Benzothiophenes

Chemical Structure| 22720-75-8

[ 22720-75-8 ]

2-Acetylbenzothiophene

Similarity: 0.90

Chemical Structure| 1195-14-8

[ 1195-14-8 ]

2-Methylbenzo[b]thiophene

Similarity: 0.83

Chemical Structure| 95-15-8

[ 95-15-8 ]

Thianaphthene

Similarity: 0.80

Chemical Structure| 1735-13-3

[ 1735-13-3 ]

4-Methylbenzo[b]thiophene-2-carboxylic acid

Similarity: 0.79

Chemical Structure| 5381-20-4

[ 5381-20-4 ]

Benzo[b]thiophene-3-carbaldehyde

Similarity: 0.79